INVANZ

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug INVANZ contains one active pharmaceutical ingredient (API):

1	Ertapenem UNII 2T90KE67L0 - ERTAPENEM SODIUM
	Ertapenem inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). In Escherichia coli, affinity is strongest to PBPs 2 and 3.
	Read more about Ertapenem

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INVANZ Powder for concentrate for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DH03	Ertapenem	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DH Carbapenems
Discover more medicines within J01DH03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	525501301159216
CA	Health Products and Food Branch	02247437
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	24.529-06-02
EE	Ravimiamet	1111431, 1131062
ES	Centro de información online de medicamentos de la AEMPS	02216001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	010234
FR	Base de données publique des médicaments	65077051
GB	Medicines & Healthcare Products Regulatory Agency	47799
HK	Department of Health Drug Office	51101
IL	מִשְׂרַד הַבְּרִיאוּת	7749
LT	Valstybinė vaistų kontrolės tarnyba	1011780, 1028456
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	161M2001
NL	Z-Index G-Standaard, PRK	63525
NZ	Medicines and Medical Devices Safety Authority	10048
PL	Rejestru Produktów Leczniczych	100113215
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64643001, W64643002
SG	Health Sciences Authority	11855P
TN	Direction de la Pharmacie et du Médicament	7013121H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699636790205
US	FDA, National Drug Code	0006-3843
ZA	Health Products Regulatory Authority	37/20.1.1/0424